Agilent Buys Cancer Diagnostics Firm Dako For $2.2 Billion

Santa Clara-based Agilent said Thurdsay that it has acquired Daiko, a Denmark-based cancer diagnostics firm, for $2.2 billion. Agilent said the deal is the largest acquisition in its history. Dako will go to complement Agilent's existing bio-analytical measurement business. Agilent was advised by Credit Suisse Securities in the deal.